RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.66%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$838M
AUM Growth
+$838M
(+5.2%)
Cap. Flow
-$80.4M
Cap. Flow
% of AUM
-9.6%
Top 10 Holdings %
Top 10 Hldgs %
41.9%
Holding
74
New
19
Increased
15
Reduced
20
Closed
19
Top Buys
| 1 |
Agilent Technologies
A
|
$43.2M |
| 2 |
Bausch Health
BHC
|
$39.2M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
$23.8M |
| 4 |
HCA Healthcare
HCA
|
$23.8M |
| 5 |
Prothena Corp
PRTA
|
$21.1M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$70.9M |
| 2 |
Gilead Sciences
GILD
|
$48.6M |
| 3 |
Zimmer Biomet
ZBH
|
$34.3M |
| 4 |
CELG
Celgene Corp
CELG
|
$30.9M |
| 5 |
AstraZeneca
AZN
|
$30.3M |
Sector Composition
| 1 | Healthcare | 80.49% |
| 2 | Technology | 2.82% |
| 3 | Communication Services | 1.03% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $50.7M | 6.06% | 246,398 +74,158 | +43% | +$15.3M |
|
|
2
HCA Healthcare
HCA
$94.5B
| $45.8M | 5.47% | 872,589 +453,489 | +108% | +$23.8M |
|
|
3
Agilent Technologies
A
$35.7B
| $43.2M | 5.16% | +772,994 | New | +$43.2M |
|
|
4
Bausch Health
BHC
$2.74B
| $39.2M | 4.68% | +297,136 | New | +$39.2M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $35.5M | 4.24% | 513,198 -59,072 | -10% | -$4.09M |
|
6
Tenet Healthcare
THC
$16.3B
| $33.8M | 4.04% | 789,562 +328,160 | +71% | +$14M |
|
7
Globus Medical
GMED
$8.27B
| $28.3M | 3.37% | 1,062,952 -23,685 | -2% | -$630K |
|
|
HTWR
8
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $27.4M | 3.27% | 291,974 +69,951 | +32% | +$6.56M |
|
|
RAD
9
DELISTED
Rite Aid Corporation
RAD
| $23.8M | 2.85% | +3,801,800 | New | +$23.8M |
|
|
TVTY
10
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $23.2M | 2.77% | 1,354,832 +508,419 | +60% | +$8.71M |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $23M | 2.74% | 4,882,930 +422,242 | +9% | +$1.98M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $21.7M | 2.6% | 418,500 +17,630 | +4% | +$916K |
|
13
Insulet
PODD
$23.9B
| $21.7M | 2.59% | 457,048 +94,012 | +26% | +$4.46M |
|
|
14
Prothena Corp
PRTA
$441M
| $21.4M | 2.56% | 559,611 +550,511 | +6,050% | +$21.1M |
|
|
CSLT
15
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $20.8M | 2.49% | +1,184,347 | New | +$20.8M |
|
|
CMRX
16
DELISTED
Chimerix, Inc.
CMRX
| $20.4M | 2.44% | 895,006 +148,601 | +20% | +$3.39M |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $20M | 2.39% | 521,301 -29,613 | -5% | -$1.14M |
|
18
Jazz Pharmaceuticals
JAZZ
$7.75B
| $19.8M | 2.37% | 142,886 -39,675 | -22% | -$5.5M |
|
|
GWPH
19
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.2M | 2.29% | 323,583 -36,394 | -10% | -$2.16M |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.2M | 2.17% | +1,001,060 | New | +$18.2M |
|
21
Puma Biotechnology
PBYI
$254M
| $17.9M | 2.14% | 172,092 -58,581 | -25% | -$6.1M |
|
|
KYTH
22
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $17.6M | 2.1% | 443,326 -114,435 | -21% | -$4.55M |
|
23
Amicus Therapeutics
FOLD
$2.34B
| $17.6M | 2.1% | 8,496,538 -151,549 | -2% | -$314K |
|
|
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $16.9M | 2.01% | 51,113 -214,836 | -81% | -$70.9M |
|
25
Celldex Therapeutics
CLDX
$1.47B
| $15.3M | 1.82% | 863,947 +465,996 | +117% | +$8.23M |
|